SINGAPORE—China is racing toward economic self-sufficiency by weaning itself off American technology. But it has made a ...

Beijing Biostar Pharmaceuticals Co., Ltd. Class H ( ($HK:2563) ) has shared an announcement. Beijing Biostar Pharmaceuticals Co., Ltd. announced a ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

As a leader in its category, Sinotau is probably hoping to follow in the footsteps of Hengrui Pharmaceuticals (1276.HK; ...

View today's Beijing SL Pharmaceutical Co Ltd stock price and latest 002038 news and analysis. Create real-time notifications to follow any changes in the live stock price.

View real-time Beijing Biostar Pharmaceuticals (2563) live share price and historical data, charts, technical analysis, financial reports and other HK:2563 stock data today.

Beijing Tide Pharmaceutical Co. Ltd. has identified protein arginine N-methyltransferase 5 (PRMT5) inhibitors reported to be useful for the treatment of cancer and myelofibrosis.

European companies operating in China say the market has become increasingly challenging because of weak economic demand and ...

Co. Ltd. and Nanjing Chia Tai Tianqing Pharmaceutical Co. Ltd. have announced IND clearance by China’s National Medical Products Administration (NMPA) for NTB-003 (formerly BCG-009) for thyroid eye ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

In late April, Trump said pharmaceutical companies were “going to have to ... Chinese manufacturers have also benefited from Beijing’s policy incentives and subsidies for the pharmaceutical ...